GlaxoSmithKline
European regulators approve GSK’s Strivelis therapy for children with combined immunodeficiency
01 Jun 2016
GlaxoSmithKline’s majority-owned HIV business to buy drugs from US rival Bristol-Myers Squibb
18 Dec 2015
CCI Imposes Rs64 crore fine on GlaxoSmithKline, Sanofi
06 Jun 2015
CCI order comes on a complaint by Bio-Med, which alleged that GlaxoSmithKline and Sanofi collided in the tendering for meningitis vaccines in contravention of the provisions of the anti-trust Act, with passive help from the government
Novartis-GSK business deal gets CCI nod
23 Dec 2014
GSK abandons sale of older drugs portfolio
05 Dec 2014
GlaxoSmithKline's $1.57-bn restructuring to hit US jobs
04 Dec 2014
GSK is struggling with declining sales, especially in the US, mainly due to a fall in its respiratory business, which accounted for 30 per cent of its global sales last year
Ebola virus gives birth to a new vaccine
28 Nov 2014
Over the long term, GlaxoSmithKline's new vaccine is intended to protect against all Ebola outbreaks, and the drug maker hopes to produce one million doses a month of the vaccine by the end of 2015
